N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-t-Butyloxycarbonyl-N-delta-i-Propyl-L-Ornithine is a heavily protected ornithine derivative tailored for solid-phase synthesis. The Fmoc and Boc groups independently control N-terminal and side-chain reactivity. The isopropyl substitution modulates steric bulk and hydrophobicity. Researchers employ this building block to construct branched peptides, peptidomimetics, and polyamine-like side chains.
CAT No: R2534
CAS No:1372560-46-7
Synonyms/Alias:1372560-46-7;Fmoc-Orn(iPr,Boc)-OH;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-delta-t-butyloxycarbonyl-N-delta-i-propyl-L-ornithine;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxycarbonyl-propan-2-ylamino]pentanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((tert-butoxycarbonyl)(isopropyl)amino)pentanoic acid;Fmoc-L-Orn(Boc,iPr)-OH;DOIRWBXTHKYGSF-DEOSSOPVSA-N;MFCD31380686;
1. Cationic cell-penetrating peptides are potent furin inhibitors
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.